Truist Securities Reiterates Buy Rating on Axsome Therapeutics (AXSM)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: AXSM) | Delayed: 145.04 -11.03 (7.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $156.07 | 52 Week High | $15.74 | |||
| Open | $154.66 | 52 Week Low | $5.37 | |||
| Day High | $154.74 | P/E | N/A | |||
| Day Low | $143.90 | EPS | $0.00 | |||
| Volume | 1,593,549 | |||||
